Salute e Benessere

FMI Reports Strong 11.7% CAGR Growth Outlook for the GLP-1 Receptor Agonist…

Manufacturers Accelerate Innovation as Demand for Metabolic Therapies Intensifies Manufacturers Accelerate Innovation as Demand for Metabolic Therapies Intensifies Pharmaceutical manufacturers are rapidly advancingself-administration devices,parenteral innovations, andcombination therapiesto elevate patient adherence and treatment outcomes. The industry is experiencing: "GLP-1 receptor agonists have evolved from single-indication diabetes drugs to multi-benefit metabolic...
PR Newswire
03/12/2025

Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology…

Luke brings more than 25 years of international experience in oncology drug development, clinical operations, and strategic partnership management across the biotech and CRO sectors. He has led global oncology programs from first-in-human and translational research through pivotal Phase III trials and regulatory submissions, driving operational excellence and scientific rigor throughout the process. Luke brings more than 25 years of international experience in oncology drug development,...
PR Newswire
03/12/2025

Plant Extracts Market worth $85.28 billion by 2030 - Exclusive Report by…

Plant Extracts Market Size & Forecast Plant Extracts Market Size & Forecast Plant Extracts Market Trends & Insights: Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=942 Demand for plant extracts is expected to rise strongly in the coming years as consumers increasingly shift toward natural, clean-label, and botanical ingredients for health, wellness, and safe nutrition. With growing awareness of the limitations and side effects...
PR Newswire
03/12/2025

World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking…

SHIYA 20 is among the first fully integrated 3D digital microsurgery platforms, unifying visualization, ergonomics, and data capture into one surgeon-centered system. Over the past year, Prof. Hong's intensive hands-on experience with SHIYA 20 in live surgeries and global training programs has provided meaningful real-world validation for surgeons and hospitals considering next-generation digital visualization technologies. SHIYA 20 is among the first fully integrated 3D digital microsurgery...
PR Newswire
03/12/2025

S3 Connected Health Receives Frost & Sullivan's 2025 Global Company of the Year…

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. S3 Connected Health excelled in both, demonstrating exceptional alignment between market demand and strategic initiatives, delivered with scale, quality, and operational consistency. "S3 Connected Health focuses on implementing best practices for consistency and quality of delivery that resonate with its clients," said Bhaskar…
PR Newswire
03/12/2025

Daewoong Pharmaceutical Holds Nabota Master Class in Saudi Arabia

To date, Nabota has expanded into 10 countries in the Middle East—more markets than any other Korean toxin brand—achieving rapid growth in key markets such as Saudi Arabia and the UAE. In Saudi Arabia, the largest aesthetic market in the region, Nabota has continued to gain market share since its launch, solidifying its presence through consistent clinical performance. To date, Nabota has expanded into 10 countries in the Middle East—more markets than any other Korean toxin brand—achieving...
PR Newswire
03/12/2025

Brainomix Announces New Study Published in Lancet Digital Health Demonstrating…

"As a Company that prides itself on a foundation of evidence-based medicine, we are delighted with the publication of this landmark study of Brainomix 360 Stroke in Lancet Digital Health. The significant increase in mechanical thrombectomy and intravenous thrombolysis with an associated improvement in clinical outcomes validates what we have seen in other studies, but at an unprecedented scale," said Dr George Harston, Chief Medical and Innovation Officer, Brainomix, and Consultant…
PR Newswire
03/12/2025

Narcolepsy Market is Projected to Grow at a CAGR of 5.6% During the Forecast…

Narcolepsy Market Summary Narcolepsy Market Summary Discover the new narcolepsy treatment @Narcolepsy Treatment Market Key Factors Driving the Growth of the Narcolepsy Market Rising Diagnosed Narcolepsy Prevalence In 2024, DelveInsight estimated around360,000diagnosed prevalent cases of narcolepsy across the 7MM, underscoring its significant clinical burden and growing recognition as a distinct neurological disorder. These number are further expected to grow by...
PR Newswire
02/12/2025

THE U.S. POINTER STRUCTURED HEALTHY LIFESTYLE PROGRAM -- PREVIOUSLY SHOWN TO…

SAN DIEGO, Dec. 2, 2025 /PRNewswire/ -- A two-year multicomponent healthy lifestyle intervention with regular, structured support — which has already shown that it can improve cognition in adults at risk for cognitive decline — may also improve blood pressure regulation and reduce hourly sleep apnea respiratory events, according to new data reported today at CTAD 2025 in San Diego. The intervention may also protect against the negative cognitive effects of certain Alzheimer's disease-related…
PR Newswire
02/12/2025

Festive Freak-Out: Over Half of Brits Say Christmas Is More Stress Than Sparkle

When asked what - or who - causes the most festive stress, 13% of Brits say their children, 9% their partners, and another 9% confess they're their own biggest source of stress. Meanwhile, gift wrapping tops the list of Christmas traditions that secretly drive people mad (19%), followed by the post-Christmas clean up (19%) and gift buying (17%). When asked what - or who - causes the most festive stress, 13% of Brits say their children, 9% their partners, and another 9% confess they're their…
PR Newswire
02/12/2025

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following…

Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that Chief Executive Officer Greg Siokas has further increased his ownership in the Company through continued share acquisitions during November 2025.Specifically, between 19 November and 28 November 2025, Mr. Siokas executed five transactions, acquiring 301,101 shares.So far in 2025, he has added 3,398,055 shares to his holdings...
Nasdaq GlobeNewswire
02/12/2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 48 - 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from November 24th to November 28th 2025 Name of the issueIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1124/11/2025FR0010259150300...
Nasdaq GlobeNewswire
02/12/2025

GUERBET : Adjustment of 2025 financial targets.

Adjustment of 2025 financial targetsVillepinte, 2 December 2025, 5.45 p.m.:Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing a downward revision to its financial targets for full-year 2025.Following an inspection by the U.S. Food and Drug Administration (FDA) during the first half of the year, the Guerbet Group developed and initiated the implementation of a compliance plan at its Raleigh site in the United States...
Nasdaq GlobeNewswire
02/12/2025

Surgical Gowns and Drapes Market worth $6.01 billion by 2030 |…

Surgical Gowns and Drapes Market Size & Forecast: Surgical Gowns and Drapes Market Size & Forecast: Surgical Gowns and Drapes Trends & Insights: Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210282118 The surgical gowns and drapes market is experiencing significant growth driven by several key factors. The increasing prevalence of healthcare-associated infections (HAIs) and the rising number of surgeries highlight the critical need for...
PR Newswire
02/12/2025

BetaGlue Therapeutics Expands its Clinical Trial in Italy after obtaining from…

®Therapeutics (“BetaGlue” or the “Company”) a pioneering Italian clinical-stage oncology company developing an innovative radiotherapy solution for the targeted treatment of solid tumours, is proud to announce that the Italian Ministry of Health (MOH) has approved its Clinical Trial Application for YntraDose ®in the treatment of unresectable Locally Advanced Pancreatic Ductal Adenocarcinoma (LA-PDAC). This authorization follows the recent Clinical Trial Approval from the UK’s Medicines...
Nasdaq GlobeNewswire
02/12/2025

Vaderis Therapeutics Announces The New England Journal of Medicine Publishes…

"These early data suggest that engasertib's targeted AKT inhibition has the potential to deliver clinically meaningful improvements in bleeding for patients with HHT. These findings provide encouraging signs that we may be on a promising path toward a much-needed treatment option for this community, which remains without approved therapies," said Hanny Al-Samkari, MD, The Peggy S. Blitz Endowed Chair in Hematology/Oncology at the Mass General Brigham Cancer Institute, Associate…
PR Newswire
02/12/2025

Frost & Sullivan: Health Recovery Solutions Receives the 2025 North American…

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. HRS excelled in both, demonstrating the ability to align strategic initiatives with provider needs while executing them with consistency, adaptability, and scale. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. HRS excelled in both,...
PR Newswire
02/12/2025

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company

TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it intends to develop its fully human anti-IL-6 receptor (IL-6R) monoclonal antibody, TZLS-501, and related assets (together “TZLS-501”) via a spinout into a separate publicly traded company, to enhance the strategic focus of each company and to drive value for shareholders. Tiziana shareholders at the record date will retain value from TZLS-501 through the...
Nasdaq GlobeNewswire
02/12/2025

Prefilled Syringes (PFS) Market Size to Grow USD 32.98 Billion by 2035 at a CAGR…

The landscape is transitioning from conventional vials to smart, polymer-based, safety-engineered, and auto-injector–compatible prefilled formats, enabling enhanced drug stability, reduced contamination risk, and superior usability across home-care and clinical settings. The landscape is transitioning from conventional vials to smart, polymer-based, safety-engineered, and auto-injector–compatible prefilled formats, enabling enhanced drug stability, reduced contamination risk, and superior...
PR Newswire
02/12/2025

Prescription Drugs Market Poised for Substantial Growth, Driven by Novel…

Download PDF Brochure: https://www.datamintelligence.com/download-sample/prescription-drugs-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/prescription-drugs-market Browse in-depth TOC on "Prescription Drugs Market" 70 – Tables 66 – Figures 195 – Pages Market Dynamics: Catalysts and Strategic Imperatives for Growth The momentum of the global prescription drugs sector is significantly propelled by several intersecting growth drivers...
PR Newswire
02/12/2025

Pharmaceutical Grade Sodium Chloride Market worth $0.77 billion by 2030 -…

Pharmaceutical Grade Sodium Chloride Market Size & Forecast: Pharmaceutical Grade Sodium Chloride Market Size & Forecast: Pharmaceutical Grade Sodium Chloride Market Trends & Insights: Browse in-depth TOC on "Pharmaceutical Grade Sodium Chloride Market" 200 - Tables 50 - Figures 250 - Pages The pharmaceutical-grade sodium chloride market is expected to grow due to the rising demand for IV fluids, injectables, dialysis solutions, and oral rehydration therapies,...
PR Newswire
02/12/2025

bit.bio Publishes 2025 Sustainability Report

Male and female donor–derived cell lines and enhanced governance frameworks strengthen ethical and scientifically relevant research practices Male and female donor–derived cell lines and enhanced governance frameworks strengthen ethical and scientifically relevant research practices CAMBRIDGE, England , Dec. 2, 2025 /PRNewswire/ -- bit.bio , the global leader in cell programming technology, today announces the publication of its 2025 Corporate Sustainability Report ,...
PR Newswire
02/12/2025

Neusoft Medical Systems Unveils World's First 8cm Wide-Coverage Photon-Counting…

"We are honored to present advanced technologies that deliver superior imaging performance and intelligent care on this global stage," said Zhang Dan, Vice President of Neusoft Medical and General Manager of the International Business Center. "From the revolutionary NeuViz P10 photon-counting CT to our comprehensive AI-driven clinical platforms, each innovation is built on deep insights into user needs. We are committed to providing our global partners with tools that enhance…
PR Newswire
02/12/2025

2026 RANK PRIZES FOR NUTRITION AND OPTOELECTRONICS ANNOUNCED

Rank Prize in Nutrition Rank Prize in Nutrition ProfessorDavid E. Salt(University ofNottingham ) and ProfessorMartin Broadley(Rothamsted Research and University ofNottingham ) are the winners of the 2026 Rank Prize for Nutrition. Fusing advances in high-throughput elemental profiling with genetics, their ground-breaking research has revealed how plants accumulate mineral nutrients and trace elements from the soil. By profiling soil and crop quality, their work is transforming...
PR Newswire
02/12/2025
Altri  Comunicati